GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Centogene NV (NAS:CNTG) » Definitions » Float Percentage Of Total Shares Outstanding

Centogene NV (Centogene NV) Float Percentage Of Total Shares Outstanding : 42.97% (As of Apr. 28, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Centogene NV Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Centogene NV's float shares is 11.98 Mil. Centogene NV's total shares outstanding is 27.87 Mil. Centogene NV's float percentage of total shares outstanding is 42.97%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Centogene NV's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Centogene NV's Institutional Ownership is 0.15%.

Centogene NV Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Centogene NV's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=11.98/27.87
=42.97%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Centogene NV (Centogene NV) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Centogene NV (NAS:CNTG) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
STIM AKUMQ LMDX XGN MYNZ DRIO CHEK OCX TTOO DMTK TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
39K:Germany
Address
Am Strande 7, Rostock, MV, DEU, 18055
Website
https://www.centogene.com
Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company operates in three segments: pharmaceutical, diagnostics, and COVID-19. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients.